D
Recursion Pharmaceuticals, Inc. RXRX
$4.94 $0.163.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -76.23% -121.60% -92.38% -3.04% -27.13%
Total Depreciation and Amortization 165.93% 162.04% 71.47% -5.01% 61.79%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 166.51% 214.38% 96.49% 57.55% -1.08%
Change in Net Operating Assets 579.32% 83.95% 153.66% 159.75% 27.54%
Cash from Operations 7.06% -28.99% -55.82% 18.78% -21.87%
Capital Expenditure -166.50% 72.46% 37.20% -512.35% 70.21%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 390,387.32% -- --
Divestitures -- -- -- -- --
Other Investing Activities 11.40% -- 0.00% -100.00% --
Cash from Investing -38.88% -9.27% 11,171.38% -1,214.70% -103.70%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -7,915.38% -7,773.08% -202.74% -9,429.17% -8.33%
Issuance of Common Stock -60.96% 205.78% -84.34% -65.14% 6,804.96%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -62.88% 191.62% -86.81% -69.38% 6,848.03%
Foreign Exchange rate Adjustments 7,943.22% 2,306.85% -2,900.00% 450.43% -165.19%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -86.02% 1.48% 3,863.80% -139.19% 369.41%